Larvol Delta - AVEROA-Submits-Marketing-Authorisation-Application-to-the-European-Medicines-Agency-Seeking-Approval-of-AVA1014-for-Treating-Complications-Associated-with-Chronic-Kidney-Disease

Auryxia (ferric citrate) - Japan Tobacco, Akebia Therap, Averoa

https://www.globenewswire.com/news-release/2024/04/23/2867475/0/en/AVEROA-Submits-Marketing-Authorisation-Application-to-the-European-Medicines-Agency-Seeking-Approval-of-AVA1014-for-Treating-Complications-Associated-with-Chronic-Kidney-Disease.html

Apr 23, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next